Psychogenic pain and depressive disorders: an empirical study.
A sample of 31 patients of both sexes suffering from psychogenic pain disorder (DSM-III) were studied in order to test if their clinical and biological features as well as their response to antidepressant treatment support the hypothesis that relates this syndrome to depressive disorders. Biological variables were basal cortisol and dexamethasone suppression test, and treatment consisted of daily administration of 100-175 mg of imipramine for a period of 5 months. Mood state was evaluated by the Hamilton scale and pain was assessed through visual analogue scales immediately before starting treatment and 3 months later. There was a low prevalence of non-suppressors (9.6%) and all patients significantly improved in mood and pain after antidepressant treatment. However, general results support both the hypothesis linking psychogenic pain to depressive disorders and its possible understanding in terms of failed adjustment processes.
Valdés
M
M
Department of Psychiatry and Medical Psychology, School of Medicine, University of Barcelona, Spain.
García
L
L
Treserra
J
J
de Pablo
J
J
de Flores
T
T
D002940:Circadian Rhythm; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy / Q000523:psychology*; D003907:Dexamethasone; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000097:blood / Q000188:drug therapy / Q000523:psychology*; D010147:Pain Measurement; D011602:Psychophysiologic Disorders / Q000097:blood / Q000188:drug therapy / Q000523:psychology*; D013001:Somatoform Disorders / Q000523:psychology
D003907:Dexamethasone; D007099:Imipramine; D006854:Hydrocortisone